These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18285331)

  • 1. Human biochemistry of the isoprostane pathway.
    Milne GL; Yin H; Morrow JD
    J Biol Chem; 2008 Jun; 283(23):15533-7. PubMed ID: 18285331
    [No Abstract]   [Full Text] [Related]  

  • 2. Profiling of oxidized lipid products of marine fish under acute oxidative stress.
    Chung ML; Lee KY; Lee CY
    Food Chem Toxicol; 2013 Mar; 53():205-13. PubMed ID: 23220612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid peroxidation and neurodegenerative disease.
    Reed TT
    Free Radic Biol Med; 2011 Oct; 51(7):1302-19. PubMed ID: 21782935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of novel isoprostane-like compounds from docosahexaenoic acid.
    Morrow JD; Tapper AR; Zackert WE; Yang J; Sanchez SC; Montine TJ; Roberts LJ
    Adv Exp Med Biol; 1999; 469():343-7. PubMed ID: 10667351
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and α-linolenic acids; bioactivities and potential use as biomarkers.
    Galano JM; Lee JC; Gladine C; Comte B; Le Guennec JY; Oger C; Durand T
    Biochim Biophys Acta; 2015 Apr; 1851(4):446-55. PubMed ID: 25463478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
    Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
    Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation.
    Roberts LJ; Fessel JP; Davies SS
    Brain Pathol; 2005 Apr; 15(2):143-8. PubMed ID: 15912887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation, isoprostanes and vascular damage.
    Minuz P; Fava C; Lechi A
    Pharmacol Rep; 2006; 58 Suppl():57-68. PubMed ID: 17332673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid.
    Fam SS; Murphey LJ; Terry ES; Zackert WE; Chen Y; Gao L; Pandalai S; Milne GL; Roberts LJ; Porter NA; Montine TJ; Morrow JD
    J Biol Chem; 2002 Sep; 277(39):36076-84. PubMed ID: 12133837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.
    Roberts LJ; Fessel JP
    Chem Phys Lipids; 2004 Mar; 128(1-2):173-86. PubMed ID: 15037162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
    Musiek ES; Yin H; Milne GL; Morrow JD
    Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.
    Greco A; Minghetti L
    Curr Neurovasc Res; 2004 Oct; 1(4):341-54. PubMed ID: 16181083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?
    Roy J; Le Guennec JY; Galano JM; Thireau J; Bultel-Poncé V; Demion M; Oger C; Lee JC; Durand T
    Biochimie; 2016 Jan; 120():56-61. PubMed ID: 26112019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid.
    Reich EE; Zackert WE; Brame CJ; Chen Y; Roberts LJ; Hachey DL; Montine TJ; Morrow JD
    Biochemistry; 2000 Mar; 39(9):2376-83. PubMed ID: 10694406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The present-day look at lipid peroxidation].
    Luczaj W; Skrzydlewska E
    Postepy Biochem; 2006; 52(2):173-9. PubMed ID: 17078507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.
    Miller E; Morel A; Saso L; Saluk J
    Oxid Med Cell Longev; 2014; 2014():572491. PubMed ID: 24868314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease.
    Nourooz-Zadeh J; Liu EH; Yhlen B; Anggård EE; Halliwell B
    J Neurochem; 1999 Feb; 72(2):734-40. PubMed ID: 9930747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isoprostanes and oxidative stress in brain damage in newborns].
    Minghetti L; Bernardo A; Greco A
    Ann Ist Super Sanita; 2001; 37(4):537-43. PubMed ID: 12046223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel eicosanoids. Isoprostanes and related compounds.
    Roberts LJ; Brame CJ; Chen Y; Morrow JD
    Methods Mol Biol; 1999; 120():257-85. PubMed ID: 10343322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Total Syntheses of Novel Non-Enzymatic Polyunsaturated Fatty Acid Metabolites and Their Identification in Edible Oils.
    Pavlíčková T; Bultel-Poncé V; Guy A; Rocher A; Reversat G; Vigor C; Durand T; Galano JM; Jahn U; Oger C
    Chemistry; 2020 Aug; 26(44):10090-10098. PubMed ID: 32531118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.